CahillKShehabRMHassanA. Addiction to transmucosal fentanyl: is it a cause for concern in cancer pain management. Palliat Med2015; 29: 859–860.
2.
SmithSMDartRCKatzNP. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain2013; 154: 2287–2296.
3.
HojstedJSjogrenP. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain2007; 11: 490–518.
4.
SchugSAZechDGrondS. A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage1992; 7: 259–266.
5.
ButlerSFBlackRACassidyTA. Abuse risks and routes of administration of different prescription opioid compounds and formulations. Harm Reduct J2011; 8: 29.
6.
CiceroTJEllisMSParadisA. Determinants of fentanyl and other potent μ agonist misuse in opioid-dependent individuals. Pharmacoepidemiol Drug Saf2010; 19: 10–57.63.
7.
DaviesA. Cancer-related breakthrough pain, 2nd ed.Oxford: Oxford University Press, 2012.
